Literature DB >> 16225557

Identifying and improving non-adherence in bipolar disorders.

F Colom1, E Vieta, M J Tacchi, J Sánchez-Moreno, J Scott.   

Abstract

OBJECTIVES: To review the definition of non-adherence, its clinical and economic impact and identify its role and impact in clinical practice.
METHODS: A selective review of the literature as conducted of articles and literature known to the authors.
RESULTS: There is a paucity of studies examining specifically treatment non-adherence and its consequences in bipolar disorder. Few studies have systematically examined ways in which treatment adherence can impact treatment and improve outcome.
CONCLUSION: Non-adherence is common in the management of bipolar disorder. Clinicians and Researchers alike need to remain alert and be aware of issues related to non-adherence--in particular suicide. Like other course-modifiers non-adherence has to be considered, sought and addressed, and this is perhaps best done by including psychoeducation in routine clinical care.

Entities:  

Mesh:

Year:  2005        PMID: 16225557     DOI: 10.1111/j.1399-5618.2005.00248.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  46 in total

Review 1.  Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.

Authors:  Pasquale De Fazio; Paolo Girardi; Giuseppe Maina; Massimo Carlo Mauri; Mauro Mauri; Palmiero Monteleone; Giulia Ida Perini; Giulio Perugi; Alessandro Rossi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Enhancing medication adherence: in older adults with bipolar disorder.

Authors:  Colin A Depp; Barry D Lebowitz
Journal:  Psychiatry (Edgmont)       Date:  2007-06

Review 3.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 4.  Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations.

Authors:  Edwin J M Oberjé; Reina J A de Kinderen; Silvia M A A Evers; Cees M J van Woerkum; Marijn de Bruin
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

5.  Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study.

Authors:  Susan J Wenze; Michael F Armey; Ivan W Miller
Journal:  Behav Modif       Date:  2014-01-08

6.  Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients.

Authors:  Elena Ezquiaga; Aurelio García-López; Consuelo de Dios; Jose Luis Agud; David Albillo; Lorena Vega-Piris
Journal:  Psychiatr Q       Date:  2014-12

7.  Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.

Authors:  Martha Sajatovic; Rosalinda V Ignacio; Jane A West; Kristin A Cassidy; Roknedin Safavi; Amy M Kilbourne; Frederic C Blow
Journal:  Compr Psychiatry       Date:  2008-08-23       Impact factor: 3.735

8.  Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.

Authors:  Pieter Stolk; Patrick C Souverein; Ingeborg Wilting; Hubert G M Leufkens; Donald F Klein; Stanley I Rapoport; Eibert R Heerdink
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-11-25       Impact factor: 4.006

9.  Clinical significance of mobile health assessed sleep duration and variability in bipolar disorder.

Authors:  Christopher N Kaufmann; Anda Gershon; Lisa T Eyler; Colin A Depp
Journal:  J Psychiatr Res       Date:  2016-07-09       Impact factor: 4.791

10.  Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.

Authors:  Monali Bhosle; Joshua S Benner; Mitch Dekoven; Jeff Shelton
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.